CEO Won-seok Lee Increases Stake to 8.21% via Open Market Purchases... Seen as Positive Signal for Shareholder Value


  • CEO Won-seok Lee purchased a total of 40,834 shares on the open market from May 19 to May 27, 2026, increasing his stake from 7.92% to 8.21%.
  • This insider buying indicates management's positive outlook on the company's growth prospects at the current price level (approx. 6,280 won). Insider buying by the CEO is generally viewed as a positive signal for the stock.
  • However, the purchase size is only 0.29% of total outstanding shares, limiting its short-term price impact. Additionally, the absence of a share buyback or dividend policy is a negative factor.
  • [AI Comprehensive Analysis]This disclosure is a positive event as it demonstrates management confidence through voluntary stake increase. However, the small purchase amount suggests limited immediate upside, and the key will be whether additional shareholder return policies follow.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Daehan Nupharm (054670)
  • Submission: Won-seok Lee
  • Receipt: 05-26-2026